Organon & Co. logo

Organon & Co. (7XP)

Market Closed
17 Jul, 20:00
XDUS XDUS
11. 77
+0.01
+0.1276%
- Market Cap
5.74 P/E Ratio
0.08% Div Yield
6 Volume
4.1 Eps
11.76
Previous Close
Add Transaction
Day Range
11.59 11.77
Year Range
4.97 11.86
Want to track 7XP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7XP closed yesterday higher at €11.77, an increase of 0.1276% from Thursday's close, completing a monthly increase of 0.5124% or €0.06. Over the past 12 months, 7XP stock gained 94.8675%.
7XP pays dividends to its shareholders, with the most recent payment made on Jun 11, 2026. The next estimated payment will be in In 1 month on Sep 11, 2026 for a total of €0.02.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.5589%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

7XP Chart

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.

Zacks | 3 days ago
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 2 weeks ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 3 weeks ago

Organon & Co. (7XP) FAQ

What is the stock price today?

The current price is €11.77.

On which exchange is it traded?

Organon & Co. is listed on XDUS.

What is its stock symbol?

The ticker symbol is 7XP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.08%.

What is its market cap?

As of today, no market cap data is available.

Has Organon & Co. ever had a stock split?

No, there has never been a stock split.

Organon & Co. Profile

Pharmaceuticals Industry
Healthcare Sector
Joseph T. Morrissey Jr. CEO
XDUS Exchange
US68622V1061 ISIN
US Country
10,000 Employees
11 Jun 2026 Last Dividend
- Last Split
2 Jun 2021 IPO Date

Overview

Organon & Co. is a healthcare company focused on innovating and providing a range of health solutions specifically tailored towards women's health needs both in the United States and globally. The company's diverse product offering encompasses a variety of prescription therapies and medical devices. Founded in 2020 and headquartered in Jersey City, New Jersey, Organon & Co. has quickly positioned itself as a key player in women's health, extending its reach through a broad spectrum of contraception and fertility treatments, biosimilars, and other healthcare solutions. Their mission extends to addressing critical areas such as cardiovascular health, respiratory conditions, dermatology, bone health, and non-opioid pain management, catering to a wide demographic. Through its commitment to health innovation, Organon & Co. markets its products to a vast network of stakeholders including drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions.

Products and Services

  • Nexplanon: A long-acting reversible contraceptive that offers an effective birth control option.
  • NuvaRing: A monthly vaginal ring designed for convenient contraception.
  • Cerazette: An oral contraceptive pill that helps prevent pregnancy.
  • Marvelon: A daily pill that combines progestin and estrogen to prevent pregnancy.
  • Follistim AQ: Utilized in assisted reproduction to stimulate the development of multiple ovarian follicles.
  • Elonva: An ovarian follicle stimulant for use in assisted reproductive technologies.
  • Ganirelix Acetate Injection: An injectable solution that acts as an antagonist in fertility treatments.
  • Jada: A solution for treating abnormal postpartum uterine bleeding or hemorrhage.
  • Biosimilars Portfolio: Includes immunology products like Brenzys, Renflexis, and Hadlima, along with two oncology products, Ontruzant and Aybintio, offering alternatives to existing biologic medicines.
  • Cholesterol-modifying Medicines: Managed under brands such as Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor to help control cholesterol levels.
  • Cozaar and Hyzaar: Prescribed for the treatment of hypertension.
  • Respiratory Products: Include treatments for asthma under the Singulair, Dulera, Zenhale, and Asmanex brands.
  • Seasonal Allergic Rhinitis Treatments: Products like Singulair, Nasonex, Clarinex, and Aerius are aimed at treating seasonal allergies.
  • Dermatology Products: Including treatments for skin conditions under the Diprosone and Elocon brands.
  • Bone Health Portfolio: Features the Fosamax brand for bone health management.
  • Non-opioid Pain Management Products: Offering solutions like Arcoxia, Diprospan, and Celestone for pain management without the use of opioids.
  • Proscar: Used in the treatment of symptomatic benign prostatic hyperplasia.
  • Propecia: A treatment solution for male pattern hair loss.

Contact Information

Address: 30 Hudson Street
Phone: 551 430 6000